FDA DEVICE FACTS
Prodigy Thrombectomy System
Truvic Medical, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Prodigy™ Thrombectomy System is intended for the removal of fresh, soft emboli and thrombi from vessels of the peripheral arterial and venous systems. The Penumbra Embolectomy Aspiration System (INDIGO™ Aspiration System) is intended for the removal of fresh, soft emboli and thrombi from vessels of the peripheral arterial and venous systems. Not for use in the coronaries, pulmonary vasculature, or the neurovasculature. Not for use in the coronaries or the neurovasculature. Catheter Shaft Characteristics Device Design Intravascular catheter Intravascular Embolectomy catheter Catheter Size(s) 5F, 6F, 8F 3F, 5F, 6F, 8F Useable Length(s) 50cm, 90cm, 137cm, 160cm 85cm, 115cm, 132cm, 135cm, 150cm Radiopaque Markers 90%, Platinum, 10% Iridium 90%, Platinum, 10% Iridium Hydrophilic coating Yes Yes Hydrophobic coating No No Sterilization Method Ethylene Oxide (EO) Ethylene Oxide (EO) Subject Predicate Thrombus Removal Assist Device Twist Separator Size / Length 5F, 177cm 6F, 154cm 8F, 67cm 8F, 107cm 3F, 190cm 5F, 175cm 6F, 175cm 8F, 150cm User Control Prodigy™ Hotshot™ Controller On/Off and Vent INDIGO Aspiration Tubing Valve On/Off User Control Patient Contacting? No No Material Comparison Materials for Catheter, Twist and User Control Commonly used medical grade plastics and metals Commonly used medical grade plastics and metals NON-CLINICAL TESTING / PERFORMANCE DATA: Non-clinical laboratory testing was performed on the Prodigy™ Thrombectomy System to assure compliance with all pre -specified, clinically relevant acceptance criteria and to determine substantial equivalence as it relates to the intended use. The following testing/assessments were successfully performed:
• Visual and Dimensional Verification
• Twist Distal Tip Stiffness Verification
• Kink / Bend / Flex Verification
• Tensile / Bond Strength Verification
• Positive Pressure / Liquid Leak Verification
• Vacuum / Air Leak Verification
• Lumen Integrity Verification
• Torque Strength Verification
• Burst Pressure Verification
• Fluoroscopy Validation (Visibility test)
• Simulated Use Performance Validation
• Corrosion Resistance Testing
• Coating Integrity Testing
• Acute Particulate Testing
• Drop Testing Verification
• Fatigue Testing Verification
• Component Actuation Force Testing Verification The in vitro bench tests demonstrated that the Prodigy™ Thrombectomy System met all acceptance criteria and performed similarly to the predicate device. Performance data demonstrate that the Prodigy™ Thrombectomy System devices function as intended and has a safety and effectiveness profile that is similar to the predicate devices. BIOCOMPATIBILITY: Testing was performed to assess biocompatibility of the Prodigy™ Thrombectomy System patient -contacting components. The following tests were successfully performed:
• Cytotoxicity
• Sensitization
• Intracutaneous Reactivity
• Acute Systemic Toxicity
• Material Mediated Pyrogenicity
• Hemocompatibility
• Complement Activation
• In-Vivo Thrombogenicity (from GLP animal study) Adherence to the test methodologies and standards was maintained in all biocompatibility testing described. Each of the biocompatibility tests defined above passed. There was no evidence of toxicity, sensitization, or irritation. Testing found samples to be non-hemolytic, non-activator, and non-pyrogenic. All testing was conducted in compliance with GLP regulations, 21 CFR Part 58. IN-VIVO GLP PRE-CLINICAL TESTING / PERFORMANCE DATA: A GLP animal study was performed to assess the acute and chronic safety and performance of the Prodigy™ Thrombectomy System as compared to the predicate . In-vivo thrombogenicity was also assessed. There were no complications in Prodigy™ Thrombectomy System device preparation or performance and no vascular injuries were observed. All treated vessels were free from thrombus formation in both acute and chronic cohorts. All acceptance criteria passed. The Truvic Prodigy™ Thrombectomy System was deemed equivalently safe as compared to the predicate in all measured assessments.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。